Cargando…

Targeting IL-23 in psoriasis: current perspectives

The recent advances in the understanding of psoriasis pathogenesis have clarified the pivotal role of interleukin (IL)-23. It is a heterodimeric cytokine consisting of two subunits, the unique p19 and the p40, which are shared with IL-12. The basic role of IL-23 in psoriasis is the activation and ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fotiadou, Christina, Lazaridou, Elizabeth, Sotiriou, Eleni, Ioannides, Demetrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804022/ https://www.ncbi.nlm.nih.gov/pubmed/29441315 http://dx.doi.org/10.2147/PTT.S98893

Ejemplares similares

Management of psoriasis in adolescence
por: Fotiadou, Christina, et al.
Publicado: (2014)

Psoriasis and uveitis: links and risks
por: Fotiadou, Christina, et al.
Publicado: (2019)

Rosacea and Helicobacter pylori: links and risks
por: Lazaridou, Elizabeth, et al.
Publicado: (2017)

Fungal Infections and Nail Psoriasis: An Update
por: Kyriakou, Aikaterini, et al.
Publicado: (2022)

Epidemiological trends in skin cancer
por: Apalla, Zoe, et al.
Publicado: (2017)

Patch Testing in Patients With Alopecia Areata: A Case-series Study
por: Kyrmanidou, Eirini, et al.
Publicado: (2022)

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
por: Apalla, Zoe, et al.
Publicado: (2017)

Atypical case of lichen planus recognized by dermoscopy
por: Papageorgiou, Chrysoula, et al.
Publicado: (2016)

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
por: Vakirlis, Efstratios, et al.
Publicado: (2008)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

A retrospective epidemiological study of skin diseases among pediatric population attending a tertiary dermatology referral center in Northern Greece
por: Vakirlis, Efstratios, et al.
Publicado: (2017)

Clinicopathologically problematic melanocytic tumors: a case-based review
por: Apalla, Zoe, et al.
Publicado: (2018)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

Scabies escaping detection until dermoscopy was applied
por: Lallas, Aimilios, et al.
Publicado: (2017)

Basosquamous Carcinoma: A Commentary
por: Fotiadou, Christina, et al.
Publicado: (2021)

Vulvar Aphthous Ulcer in an Adolescent Girl Suffering From COVID-19 Infection
por: Fotiadou, Christina, et al.
Publicado: (2023)

Solitary trichoepithelioma in an 8-year-old child: clinical, dermoscopic and histopathologic findings
por: Lazaridou, Elizabeth, et al.
Publicado: (2014)

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
por: Campa, Molly, et al.
Publicado: (2015)

Apremilast in Psoriasis Patients With Serious Comorbidities: a Case Series and Systematic Review of Literature
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Lallas, Aimilios, et al.
Publicado: (2016)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Apalla, Zoe, et al.
Publicado: (2021)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

Pustular psoriasis of pregnancy: current perspectives
por: Trivedi, Megha K, et al.
Publicado: (2018)

Management of scalp psoriasis: current perspectives
por: Blakely, Kim, et al.
Publicado: (2016)

Under Development JAK Inhibitors for Dermatologic Diseases
por: Sideris, Nikolaos, et al.
Publicado: (2020)

Sebaceous Neoplasms
por: Papadimitriou, Ilias, et al.
Publicado: (2023)

Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis
por: FİLİZ, Başak, et al.
Publicado: (2019)

Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders
por: Gooderham, M.J., et al.
Publicado: (2018)

Large cell acanthoma: a debate throughout the decades
por: Patsatsi, Aikaterini, et al.
Publicado: (2014)

Eccrine Poroma: Pathogenesis, New Diagnostic Tools and Association with Porocarcinoma—A Review
por: Kyrmanidou, Eirini, et al.
Publicado: (2023)

Profile of secukinumab in the treatment of psoriasis: current perspectives
por: Roman, Michael, et al.
Publicado: (2015)

Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes, Katie E, et al.
Publicado: (2016)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
por: Madonna, Stefania, et al.
Publicado: (2019)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6dvuofvrqnc7ke3me5k7vh37v9